Hematology

Clinical pharmacy services in hematology can have a significant impact, and the Pharmacy Times® Hematology resource center provides clinical news and articles about the topic. Here, visitors will find information about upcoming hematology conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?
[[thumbnail_alt_text]]
Belantamab mafodotin-blmf is the first anti-BCMA therapy approved by the FDA for the treatment of patients with relapsed or refractory multiple myeloma who received at least 4 prior therapies.
[[thumbnail_alt_text]]
As the most accessible member of the health care team, the pharmacist can provide patients with cancer with the information and support necessary to get through what might be the most challenging time of their lives. 
[[thumbnail_alt_text]]
“These new therapies allow for treatment without some of the traditional chemotherapy agents.” 
[[thumbnail_alt_text]]
The investigators found that patients with preexisting neutropenia could be managed on venetoclax, although use of G-CSF would likely also be required in conjunction with the treatment.
[[thumbnail_alt_text]]
Brexucabtagene autoleucel (Tecartus, Kite Pharma) is indicated for adult patients diagnosed with mantle cell lymphoma (MCL) who have not responded to or who have relapsed following other kinds of treatment.
[[thumbnail_alt_text]]
The review also summarized proposed mechanisms behind these wide-ranging systemic effects and provided clinical guidance for physicians, according to a press release.
[[thumbnail_alt_text]]
The test is intended to determine whether someone is currently infected with COVID-19 and if they have been infected in the past.
[[thumbnail_alt_text]]
Caroline Bernal-Silva, a patient spokesperson for the National Blood Clot Alliance, discusses a recent survey regarding patients’ fears of a life-threatening bleeding event while taking anticoagulant medications.
[[thumbnail_alt_text]]
Expert pharmacists provide community physicians with recommendations for optimizing success on treatment for patients with chronic lymphocytic leukemia (CLL).
[[thumbnail_alt_text]]
Experienced pharmacists in the management of chronic lymphocytic leukemia (CLL) discuss the impact of pharmacy-led oral chemotherapy management programs, and how they are implemented.
[[thumbnail_alt_text]]
A discussion on the economic impact that intravenous versus oral therapy has for institutions and patients.
 
[[thumbnail_alt_text]]
According to new research published in Clinical and Translational Immunology, a new cancer vaccine is ready for human trials following its success in preclinical studies.